Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1993:3:1-7.
doi: 10.1002/jso.2930530503.

Hepatic regeneration and growth factors

Affiliations
Review

Hepatic regeneration and growth factors

A Francavilla et al. J Surg Oncol Suppl. 1993.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Liver mass recovery in rats after 70% hepatectomy. Liver resection was performed as described by Higgins and Anderson [15]. Liver mass is expressed as percentage of the liver weight in the intact animal. GsF, growth stimulatory factor; GiF, growth inhibitory factor.
Fig. 2
Fig. 2
General pattern of the factors modulating liver regeneration and their time of intervention in the cell cycle. CyA, cyclosporin A; EGF, epidermal growth factor; HGF, hepatocyte growth factor; HSS, hepatic stimulatory substance; IGF, insulin-like growth factor; IL, interleukin; RPM, rapamycin; TGF, transforming growth factor.
Fig. 3
Fig. 3
SDS-PAGE and Western blot analysis of acrylamide F4 (Ac-F4). For SDS-PAGE (A) final acrylamide concentration was 16%, in Tris 0.377 M, pH 8.8. Fifteen micrograms of protein underwent electrophoresis for 50 minutes at room temperature using 150 V, constant voltage, with Tris-HCI 0.125 M and 0.192 M glycine, pH 8.3, as reservoir buffer. Western blot analysis (B) was performed using an Immobilon membrane (Millipore). Protein transfer was conducted using 3-(cyclohexylamino)-1-propano-sulfonic acid (CAPS) 10 mM with 10% methanol, pH 11, as transfer buffer (90 minutes at 4°C with 70 V constant voltage). The membrane was blocked for 30 minutes with 3% gelatin in TTBS (Tris-buffered saline with 0.2% Tween 20) and incubated, for 60 minutes, with a specific monoclonal murine antibody against hepatic stimulatory substance (HSS) [8]. The membrane was then washed with TTBS and incubated with a second antibody in 1 % gelatin, against mouse immunoglobulins, carrying alkaline-phosphate substrate. The membrane was washed with TTBS and the immunoreactive band was identified.
Fig. 4
Fig. 4
Effect of immunosuppressive agents on liver regeneration after 70% hepatectomy. [3H]thymidine incorporation and percentage of mitoses in normal and 70% hepatectomized rats treated or not treated with cyclosporin A (CyA), FK 506, and rapamycin (RPM). The animals were given oral CyA and intramuscular FK 506 or RPM at 10 mg, 1 mg, and 0.3 mg/kg body weight, respectively, for 3 days before surgery and again just after completing hepatic resection [15]. Values are the means from at least 15 rats ± SD. *, significantly different from 70% hepatectomized rats (P < .05). **, significantly different from 70% hepatectomized rats (P < .01) and CyA-treated 70% hepatectomized rats (P < .05). ***, significantly different from 70% hepatectomized rats (P < .01). Vehicle injections did not influence [3H]thymidine incorporation and percentage of mitoses in normal and 70% hepatectomized rats. PH, partial hepatectomy.
Fig. 5
Fig. 5
Possible mechanisms for the control of hepatic regeneration. The factors controlling hepatocyte proliferation are given, as described by Michalopoulos [1] (A) and Fausto [7] (B). Norepinephrine, vasopressin, and angiotensin potentiate GsF action and reduce GiF influence. For abbreviations, see Figure 2 legend.
Fig. 6
Fig. 6
Signalling pathways of growth factors. R, cell surface receptor; G, guanine nucleotide binding protein; PhlC, phospholipase C; P2, phosphatidylinositol biphosphate; TK, tyrosine kinase; In, inositol; DG, diacylglycerol; PDGF, platelet-derived growth factor.
Fig. 7
Fig. 7
Interaction of CyA and FK 506 immunophilin complex with specific intracellular proteins. CyP, cyclophilin; FKBP, FK binding protein; CaM, calmodulin; CNA-CNB, calcineurin; Im, immunophilin; D, drug.
Fig. 8
Fig. 8
Intracellular signalling pathway of FK 506 and CyA. R, cell surface receptor; G, guanine nucleotide binding protein; PhlC, phospholipase C; P2, phosphatidylinositol biphosphate; TK, tyrosine kinase; In, inositol; DG, diacylglycerol; CaM, calmodulin; CNA-CNB, calcineurin; Im, immunophilin; D, drug.

References

    1. Michalopoulos G, Houck KA, Dolan ML, Luetteke NC. Control of hepatocvte replication by two serum factors. Cancer Res. 1984;44:4414–4419. - PubMed
    1. Goldberg M. Purification and partial characterization of a liver cell proliferation factor called hepatopoietin. J Cell Biochem. 1985;27:291–302. - PubMed
    1. Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA. 1986;83:6489–6493. - PMC - PubMed
    1. Francavilla A, Ove P, Polimeno L, et al. Extraction and partial purification of a hepatic stimulatory substance in rats, mice, and dogs. Cancer Res. 1987;47:5600–5605. - PMC - PubMed
    1. Olsen PS, Boesby S, Kirkegaard P, et al. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology. 1988;8:992–996. - PubMed

Publication types

LinkOut - more resources